Original Article

Turkey Prostate Cancer Map 2021: Turkish Urooncology Association Prostate Cancer Database Report
  • Bahadır Şahin
  • Serdar Çelik
  • İlker Tinay
  • Saadettin Eskiçorapçı
  • Güven Aslan
  • Sinan Sözen
  • Süleyman Ataus
  • Levent Türkeri
Bull Urooncol 2022; 21: 1-4 DOI: 10.4274/uob.galenos.2021.2021.11.1
Do Subgroup Evaluations Provide Additional Contributions to Biochemical Recurrence in Grade Group 4 and 5 Patients? A Multicenter Study by the Turkish Urooncology Association Prostate Cancer Working Group
  • Taha Çetin
  • Serdar Çelik
  • Evren Süer
  • Sinan Sözen
  • Volkan İzol
  • Bülent Akdoğan
  • Levent Türkeri
  • Güven Aslan
  • Haluk Özen
  • Sertaç Yazıcı
  • Bahadır Şahin
  • Members of Turkish Urooncology Association
Bull Urooncol 2024; 23: 10-15 DOI: 10.4274/uob.galenos.2024.2023.11.3
Are the Recommended Criteria for Clinically Insignificant Prostate Cancer Applicable to 12-core Prostate Biopsy Scheme? A Multicentre Study of Urooncology Association, Turkey
  • Serdar Çelik
  • Fuat Kızılay
  • Kutsal Yörükoğlu
  • Haluk Özen
  • Bülent Akdoğan
  • Volkan İzol
  • Yıldırım Bayazıt
  • Güven Aslan
  • Sinan Sözen
  • Sümer Baltacı
  • Talha Müezzinoğlu
  • Fehmi Narter
  • Levent Türkeri
Bull Urooncol 2021; 20: 19-25 DOI: 10.4274/uob.galenos.2020.1677
Survival Outcomes of Treatment Modalities in Patients with Variant Histopathology of Bladder Cancer in First Transurethral Resection of the Bladder
  • Volkan İzol
  • Mutlu Değer
  • Bülent Akdoğan
  • Murat Akgül
  • Güven Aslan
  • Serdar Çelik
  • Burak Argun
  • Hayrettin Şahin
  • Sümer Baltacı
  • Bladder Cancer Study Group of Association of Urooncology, Turkey
Bull Urooncol 2024; 23: 22-28 DOI: 10.4274/uob.galenos.2023.2023.8.1
Treatment of Primary Tumor in Oligometastatic Prostate Cancer: An Observational Study of the Turkish Urooncology Association Prostate Diseases Working Group
  • Murat Yavuz Koparal
  • Tevfik Sinan Sözen
  • Güven Aslan
  • Sümer Baltacı
  • Oğuzcan Erbatu
  • Levent Türkeri
  • on Behalf of the Turkish Urooncology Association
Bull Urooncol 2023; 22: 62-67 DOI: 10.4274/uob.galenos.2023.2023.1.4
Testis-sparing Surgery in the Treatment of the Normal Contralateral Testicle: A Prospective Multicenter Bench Study Following Radical Orchiectomy
  • Tayyar Alp Özkan
  • Ata Özen
  • Şahin Kabay
  • Cavit Can
  • Ahmet Tuğrul Eruyar
  • Mustafa Açıkalın
  • Saadettin Eskiçorapçı
  • on Behalf of the Turkish Urooncology Association Kidney and Testicular Cancers Study Group
  • Levent Türkeri
Bull Urooncol 2023; 22: 89-93 DOI: 10.4274/uob.galenos.2022.2022.2.3
Determination of the PSA Cut-off Value to Predict the Clinically Significant Prostate Cancer in Patients with Positive Multiparametric MRI: A Population-based Study
  • Fuat Kızılay
  • Serdar Çelik
  • Fehmi Narter
  • Sinan Sözen
  • Haluk Özen
  • Bülent Akdoğan
  • Güven Aslan
  • Levent Türkeri
  • Volkan İzol
  • Bahadır Şahin
  • Saadettin Eskiçorapçı
  • Members of Turkish Urooncology Association
Bull Urooncol 2023; 22: 100-105 DOI: 10.4274/uob.galenos.2023.2023.1.1
What is the Optimal Time Period for Postponing Nephrectomy in Patients with Renal Cell Carcinoma of Various Stages?
  • Serdar Çelik
  • İlker Tinay
  • Sinan Sözen
  • Haluk Özen
  • Bülent Akdoğan
  • Güven Aslan
  • Sümer Baltacı
  • Evren Süer
  • Yıldırım Bayazıt
  • Volkan İzol
  • Tayyar Alp Özkan
  • Fatih Gökalp
  • Members of Turkish Urooncology Association
Bull Urooncol 2023; 22: 150-155 DOI: 10.4274/uob.galenos.2022.2022.10.2
Radical Prostatectomy Outcomes in Patients with Clinical Lymph Node Involvement from The Turkish Urooncology Database
  • Hasan Hüseyin Tavukçu
  • Oğuzcan Erbatu
  • Bülent Akdoğan
  • Volkan İzol
  • Uğur Yücetaş
  • Sinan Sözen
  • Güven Aslan
  • Bahadır Şahin
  • İlker Tinay
  • Talha Müezzinoğlu
  • Sümer Baltacı
Bull Urooncol 2021; 20: 231-235 DOI: 10.4274/uob.galenos.2021.2021.5.1

General Urooncology

Evaluation of complications in urooncologic surgeries and recommended criterias
  • Cenk Acar
  • Ali Ersin Zümrütbas
Bull Urooncol 2012; 11: 289-294
An approach to dermatological side effects of targeted therapies
  • Cemal Bilaç
  • Sedef Bayata
  • Serap Öztürkcan
Bull Urooncol 2012; 11: 295-300
Does physical activity decrease incidence of urooncologic cancers?
  • Evren Süer
  • Çağatay Göğüs
Bull Urooncol 2012; 11: 301-304

General

Basic molecular methods used in urooncology
  • Bora İrer
  • Güven Aslan
Bull Urooncol 2013; 12: 291-293